Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial

Table 2

CMV after intervention for both groups.

Time	Control		Intervention		P1
	Mean	SD	Mean	SD
Baseline	11.22	1.27	11	1.02	0.780
Month 1	11.03	1.23	10.83	1.07	0.590
Month 2	10.95	1.24	10.71	0.99	0.616
P2	0.039		0.002

SD: standard deviation, P₁: between-group value (Mann–Whitney test), P₂: within-group value (Friedman test).